The effect of pharmacologically altered gastric pH on cadmium absorption from the diet and its accumulation in murine tissues

Study on the bioaccessibility and bioavailability of Cd in contaminated rice in vitro and in vivo

Cadmium (Cd) is a widespread heavy metal pollutant in the environment that damages human health. In this study, the bioaccessibility and bioavailability of Cd in different Cd-contaminated rice (low pollution level cadmium rice (Rice-L, 0.111 mg/kg), medium pollution level cadmium rice (Rice-M, 0.400 mg/kg), and high pollution level cadmium rice (Rice-H, 0.655 mg/kg)) were estimated and determined by an in vitro digestion model Rijksinstituut voor volksgezondheiden milieu (RIVM), Caco-2 cell model, and mouse model. The results indicated that Cd in the oral cavity (15.65-28.28%) displayed the lowest bioaccessibility comparing with small intestine (90.04-94.73%) and the stomach (99.30-100.70%) in vitro after cooking. In addition, the results showed that the bioaccessibility of Cd in CdCl₂ , CdCl₂ +normal rice (Rice-N), Rice-H, Rice-M, Rice-L group were 99.29%, 92.57%, 90.04%, 94.73%, and 91.11%, respectively; the in vitro bioavailability of Cd in CdCl₂ , CdCl₂ +Rice-N, Rice-H, Rice-M, and Rice-L group were 27.50%, 20.78%, 21.90%, 26.90%, 36.46%, respectively, we found that the group of CdCl₂ is significantly higher than CdCl₂ +Rice-N and Rice-H (p < 0.05), while the targets hazard quotient (THQ) value of rice ingested without considering the in vitro bioavailability is 2.7-4.6 times than the THQ value with considered and the relative bioavailability (RBA) of Cd in Rice-L, Rice-M, Rice-H are 80.25%, 64.32%, and 60.91%, respectively. These results indicate that the rice substrate has impact on the bioaccessibility and bioavailability of Cd, and might overestimate the health risks of Cd if bioavailability was not considered. PRACTICAL APPLICATION: Studying the bioaccessibility and bioavailability of cadmium in rice is a promising strategy to obtain a more accurate human health risk assessment of cadmium exposure in rice, as well as provide a theoretical basis for the formulation of cadmium limit standard in grain, which was also conducive to the rational and full utilization of rice resources in China.

A high-calcium diet failed to rescue an osteopenia phenotype in claudin-18 knockout mice

We have recently demonstrated that mice with disruption of claudin‐18 (Cldn‐18) gene exhibited osteopenia due to increased bone resorption (BR). In this study, we found that gastric pH was significantly higher in Cldn‐18 knockout (KO) mice compared to heterozygous control mice at 10 weeks of age. To test the possibility that the increased BR in the Cldn‐18 KO mice fed a normal‐Ca diet is a consequence of decreased Ca absorption caused by increased stomach pH, we subjected KO and control mice to a normal‐Ca and high‐Ca diet at birth. Serum Ca levels were significantly lower in Cldn‐18 KO mice compared to control mice at a normal‐Ca diet but not at high‐Ca diet. Dual energy X‐ray absorptiometry revealed that a high‐Ca diet significantly increased lumbar bone mineral density (BMD), but had no effect on femur/tibia BMD in both Cldn‐18 KO and control mice compared to a normal‐Ca diet. While a high‐Ca diet did not affect volumetric BMD, trabecular, and cortical parameters of the lumbar vertebra (LV) as measured by μCT, the size of the LV did increase, in both genotypes due to reduced BR. Comparison of the skeletal phenotype of high‐Ca Cldn‐18 KO and control mice revealed that an osteopenia phenotype seen at a normal‐Ca diet was still maintained at different skeletal sites in the KO mice till 10 weeks of age. In conclusion, our findings suggest that increased BR is likely caused by direct effects of a lack of Cldn‐18 on osteoclasts rather than gastric pH changes.

In this study, we examined if calcium deficiency caused by low‐gastric acidity was the cause of osteopenia phenotype observed in claudin‐18 (Cldn‐18) knockout (KO) mice. Our findings that high‐calcium diet did not rescue the osteopenia phenotype in Cldn‐18 KO mice suggest that increased bone resorption is likely caused by direct effects of a lack of Cldn‐18 on osteoclasts rather than gastric pH changes.

Cadmium bioavailability and bioaccessibility as determined by in vitro digestion, dialysis and intestinal epithelial monolayers, and compared to in vivo data

The objective of the study was to compare in vivo estimates of Cd bioavailability in two diet materials (lettuce and durum wheat grain) with bioaccessibility estimates from three in vitro methods. For both dietary materials, the Cd was either incorporated during growth or applied topically as a soluble salt just prior to experimentation. Simulated gastric/intestinal digestion using a physiologically based extraction technique (PBET) solubilized less than 56% (lettuce) or 13% (grain) of the Cd that was either incorporated into the plant tissues during growth, or added to the plant tissues before experimentation, as Cd(NO3)2.H2O. Amended diets could not be distinguished from incorporated diets. More of the Cd solubilized from amended lettuce than from incorporated lettuce moved to the outside of MWCO 10 kD and 25 kD dialysis sacs; no difference between the amended and incorporated diets was observed for grain. The percentage of lettuce-Cd solubilized by the PBET and sorbed by Caco-2 cells was greater for incorporated than for amended lettuce; for Cd in grain, the reverse occurred. As expected, none of the in vitro estimates of bioaccessibility were the same percentage of Cd in the lettuce or grain as was measured as bioavailable in vivo. The in vitro assays all predicted that substantially less than 100% of the Cd in the foods would be bioavailable, as was identified in vivo, and simulating intestinal selectivity improved the comparison to in vivo. Some of the in vitro assays identified subtle differences between the diets (i.e., amended vs. incorporated) that were consistent with in vivo studies, and with speculated differences in Cd speciation; this suggests their potential usefulness for the study of modifiers to dietary Cd bioavailability.